Karen Hübscher
Director/Board Member bei TECAN GROUP AG
Vermögen: 360 229 $ am 31.03.2024
Aktive Positionen von Karen Hübscher
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TECAN GROUP AG | Director/Board Member | 01.04.2012 | - |
| RUTILA RESOURCES LTD | Director/Board Member | - | - |
| SANDOZ GROUP AG | Director/Board Member | 01.08.2023 | - |
| Dispopharm D&P AG | Director/Board Member | - | - |
| FibulaMedical AG | Chief Executive Officer | 01.01.2012 | - |
| Founder | 01.01.2012 | - | |
| Schweizerische Management Gesellschaft | Director/Board Member | - | - |
| IMD Scholarship Foundation | Director/Board Member | - | - |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Director/Board Member | - | - |
Karriereverlauf von Karen Hübscher
Ehemalige bekannte Positionen von Karen Hübscher
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Novartis Vaccines & Diagnostics Services AG | Corporate Officer/Principal | 01.01.2006 | 01.01.2011 |
| ░░░░░░░░ ░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Karen Hübscher
| Swiss Federal Institute of Technology | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Statistik
International
| Schweiz | 13 |
| Australien | 2 |
Operativ
| Director/Board Member | 8 |
| Chief Executive Officer | 2 |
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Non-Energy Minerals | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| TECAN GROUP AG | Health Technology |
| SANDOZ GROUP AG | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
Solvias AG
 Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |
| IMD Scholarship Foundation | |
| Schweizerische Management Gesellschaft | |
BBI Group Pty Ltd.
 BBI Group Pty Ltd. Other Metals/MineralsNon-Energy Minerals BBI Group Ltd. operates as a resource and energy exploration company. Its projects include include Balla Balla and Eucla West Mineral Sands. The company was founded on October 8, 2009 and is headquartered in Sydney, Australia. | Non-Energy Minerals |
| Dispopharm D&P AG | |
| FibulaMedical AG | |
| Novartis Vaccines & Diagnostics Services AG |
- Börse
- Insiders
- Karen Hübscher
- Erfahrung
